This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hill, S. A. Articles by Cowen, P. J. Search for Related Content PubMed PubMed Citation Articles by Hill, S. A. Articles by Cowen, P. J. Social Bookmarking                         What's this?

Acute Reboxetine Administration Increases Plasma and Salivary Cortisol

University Department of Psychiatry, Warneford Hospital, Oxford, UK

M. J. Taylor

University Department of Psychiatry, Warneford Hospital, Oxford, UK

C. J. Harmer

University Department of Psychiatry, Warneford Hospital, Oxford, UK

P. J. Cowen

University Department of Psychiatry, Warneford Hospital, Oxford, UK, phil.cowen{at}psych.ox.ac.uk

We investigated the effect of a single oral dose of the selective noradrenaline reuptake inhibitor, reboxetine (4 mg), on plasma and salivary cortisol in 24 healthy volunteers in a randomized, placebo-controlled, parallel-group design. Reboxetine significantly increased both plasma and salivary cortisol, although the correlation between the responses in plasma and saliva was modest. Our results are consistent with previous neuroendocrine challenge studies showing that potentiation of brain noradrenaline function stimulates the hypothalamic-pituitary-adrenal axis. Reboxetine-induced salivary cortisol release appears to be a simple and relatively non-invasive test of hypothalamic noradrenaline function. However, placebo-controlled, within-subject designs are likely to yield a more valid measure of noradrenaline-mediated cortisol release.

Key Words: cortisol • noradrenaline • reboxetine

Journal of Psychopharmacology, Vol. 17, No. 3, 273-275 (2003)
DOI: 10.1177/02698811030173008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. R. Chamberlain, U. Muller, S. Cleary, T. W. Robbins, and B. J. Sahakian Atomoxetine increases salivary cortisol in healthy volunteers J Psychopharmacol, July 1, 2007; 21(5): 545 - 549. [Abstract] [PDF]